Scientists have identified a rare genetic disease that can cause severe inflammation in blood vessels and damage the liver from a very young age.
The newly described condition is called Lyn kinase-associated vasculopathy and liver fibrosis, or LAVLI. The discovery could help doctors understand other diseases in which the immune system becomes dangerously overactive.
The condition is linked to changes in a gene called LYN. This gene provides instructions for making a protein known as Lyn kinase, which helps control signals inside immune cells. Normally, this signaling system helps the immune system respond to infections while preventing unnecessary inflammation.
When this control system goes wrong, however, immune cells may become too active. Instead of simply protecting the body from germs, they can produce inflammation that harms healthy tissues. Diseases caused by uncontrolled parts of the body’s early immune response are often described as autoinflammatory conditions.
LAVLI was first identified after doctors investigated a young child who developed unusual health problems shortly after birth. Genetic testing revealed a change in the LYN gene. Researchers later identified two other children with similar symptoms who also carried disease-causing changes in the same gene.
The fact that all three children became ill very early in life was an important clue. Their problems mainly affected small blood vessels and, in some cases, the liver. By comparing their symptoms and genetic results, researchers were able to connect the LYN changes with this previously unknown disease.
One of the main features was inflammation of small blood vessels in the skin. Large numbers of neutrophils, a common type of white blood cell, gathered around these vessels and contributed to tissue damage. Neutrophils normally help the body fight infections, but excessive or poorly controlled activity can also cause harmful inflammation.
Two of the children also developed liver fibrosis. Fibrosis happens when repeated injury causes scar tissue to build up in an organ. If liver scarring continues for a long time, it can interfere with the liver’s ability to perform essential jobs such as processing nutrients, removing harmful substances, and making important proteins.
Laboratory studies helped researchers understand what was happening inside the children’s cells. The altered Lyn protein was unusually active and failed to switch off properly. This appeared to disrupt normal immune signaling and encouraged excessive activity involving neutrophils.
The abnormal signals also affected cells involved in liver scarring. Together, these effects could help explain why the children developed both blood vessel inflammation and liver fibrosis. The findings show how a single genetic change can disturb several systems in the body at the same time.
The discovery may have importance beyond these few rare cases. By showing that excessive Lyn activity can drive inflammation and tissue damage, the research gives scientists another biological pathway to investigate. In the future, medicines that reduce this abnormal signaling might become possible treatments, although much more research will be needed to determine whether such approaches are safe and effective.
The work also highlights the growing value of genetic testing for children with unusual illnesses that begin very early in life. When standard tests cannot explain a combination of symptoms, studying a patient’s DNA can sometimes reveal the underlying cause. A clear genetic diagnosis can help families understand the disease and may guide doctors toward more targeted care.
Rare diseases can also teach researchers important lessons about more common illnesses. Studying an unusual genetic change can reveal how a normal immune pathway works and what happens when that pathway becomes overactive. These insights may eventually improve understanding of other conditions involving blood vessel inflammation or liver scarring.
The research was led by Dr. Adriana A. de Jesus and colleagues at the National Institute of Allergy and Infectious Diseases and collaborating institutions. The findings describing LAVLI and disease-causing LYN mutations were published in the peer-reviewed journal Nature Communications.
For the families involved, identifying the disease provides an explanation for symptoms that were previously difficult to understand. For scientists, it opens a new window into the complex relationship between genes, immune cells, blood vessels, and the liver. Continued research may eventually lead to better ways to diagnose and treat this newly recognized condition.
If you care about liver health, please read studies about a diet that can treat fatty liver disease and obesity, and coffee drinkers may halve their risk of liver cancer.
For more health information, please see recent studies that anti-inflammatory diet could help prevent fatty liver disease, and results showing vitamin D could help prevent non-alcoholic fatty liver disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
